LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Normalized Growth Rate Inhibition Value | Standard Error of the Mean for Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 0.5311 | 0.0238 | 0.4044 | 0.0534 |
MCF7 | GSK1904529A | 1.11 | uM | LJP6 | 0.5030 | 0.0176 | 0.3631 | 0.0465 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 0.4994 | 0.0118 | 0.3580 | 0.0397 |
MCF7 | GSK1904529A | 10 | uM | LJP6 | 0.4745 | 0.0227 | 0.3192 | 0.0527 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 0.7542 | 0.0152 | 0.7214 | 0.0082 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 0.7824 | 0.0483 | 0.7488 | 0.0663 |
MCF7 | Linsitinib | 0.37 | uM | LJP5 | 0.6325 | 0.0733 | 0.5548 | 0.1094 |
MCF7 | Linsitinib | 1.11 | uM | LJP5 | 0.5504 | 0.0434 | 0.4494 | 0.0809 |
MCF7 | Linsitinib | 3.33 | uM | LJP5 | 0.5015 | 0.0215 | 0.3834 | 0.0524 |
MCF7 | Linsitinib | 10 | uM | LJP5 | 0.4269 | 0.0176 | 0.2706 | 0.0515 |
MCF7 | Ruxolitinib | 0.04 | uM | LJP5 | 0.9717 | 0.0329 | 0.9671 | 0.0360 |
MCF7 | Ruxolitinib | 0.12 | uM | LJP5 | 0.9503 | 0.0255 | 0.9477 | 0.0272 |
MCF7 | Ruxolitinib | 0.37 | uM | LJP5 | 0.9658 | 0.0212 | 0.9627 | 0.0245 |
MCF7 | Ruxolitinib | 1.11 | uM | LJP5 | 1.0500 | 0.0213 | 1.0503 | 0.0220 |
MCF7 | Ruxolitinib | 3.33 | uM | LJP5 | 1.0498 | 0.0137 | 1.0520 | 0.0156 |
MCF7 | Ruxolitinib | 10 | uM | LJP5 | 0.8040 | 0.0297 | 0.7775 | 0.0431 |
MCF7 | Momelotinib | 0.04 | uM | LJP5 | 0.9209 | 0.0094 | 0.9123 | 0.0139 |
MCF7 | Momelotinib | 0.12 | uM | LJP5 | 0.9081 | 0.0471 | 0.8957 | 0.0568 |
MCF7 | Momelotinib | 0.37 | uM | LJP5 | 0.8501 | 0.0411 | 0.8304 | 0.0533 |
MCF7 | Momelotinib | 1.11 | uM | LJP5 | 0.6816 | 0.0258 | 0.6276 | 0.0481 |
MCF7 | Momelotinib | 3.33 | uM | LJP5 | 0.4731 | 0.0612 | 0.3323 | 0.1137 |
MCF7 | Momelotinib | 10 | uM | LJP5 | 0.3055 | 0.0134 | 0.0654 | 0.0224 |
MCF7 | Fedratinib | 0.04 | uM | LJP5 | 1.0201 | 0.0322 | 1.0189 | 0.0345 |
MCF7 | Fedratinib | 0.12 | uM | LJP5 | 0.9672 | 0.0397 | 0.9602 | 0.0455 |
MCF7 | Fedratinib | 0.37 | uM | LJP5 | 0.8367 | 0.0478 | 0.8126 | 0.0612 |